Cargando…

Efficacy and safety of molnupiravir for COVID-19 patients

Detalles Bibliográficos
Autores principales:	Fatima, Maurish, Azeem, Saleha, Saeed, Junaid, Shahid, Abia, Cheema, Huzaifa Ahmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130682/ https://www.ncbi.nlm.nih.gov/pubmed/35649740 http://dx.doi.org/10.1016/j.ejim.2022.05.024

Ejemplares similares

Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022)

Devastating floods in South Asia: The inequitable repercussions of climate change and an urgent appeal for action
por: Azeem, Saleha, et al.
Publicado: (2023)

The misuse of funnel plots in meta-analyses of proportions: are they really useful?
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022)

No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022)

The usefulness of electrocardiogram in the recognition of cardiac transplant rejection
por: Cheema, Huzaifa A., et al.
Publicado: (2022)

The effect of molnupiravir on post-acute outcome of COVID-19 survivors
por: Hsu, Wan-Hsuan, et al.
Publicado: (2023)

The cholera outbreak in Lahore, Pakistan: challenges, efforts and recommendations
por: Naveed, Aiman, et al.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: A systematic review
por: Fatima, Maurish, et al.
Publicado: (2022)

Probiotics for the Prevention of Ventilator-Associated Pneumonia: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022)

Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India
por: Sinha, Shubhadeep, et al.
Publicado: (2022)

Development of myocarditis and pericarditis after COVID‐19 vaccination: A deeper insight
por: Fatima, Maurish, et al.
Publicado: (2023)

Vaccine apartheid: the separation of the world’s poorest and most vulnerable and the birth of Omicron
por: Prasad, Sakshi, et al.
Publicado: (2022)

Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review
por: Mali, Kalpana Ramanna, et al.
Publicado: (2022)

Vitamin D supplementation for the prevention of total cancer incidence and mortality: An updated systematic review and meta-analysis
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022)

Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase()
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Efficacy and Safety of Enteral Human Recombinant Insulin to Reduce the Time to Full Enteral Feeding in Preterm Infants: A Meta-Analytical Study
por: Qudsia, Faiza, et al.
Publicado: (2023)

Nirmatrelvir and Molnupiravir and Post–COVID-19 Condition in Older Patients
por: Fung, Kin Wah, et al.
Publicado: (2023)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022)

In vitro and in vivo efficacy of Molnupiravir against Zika virus infections
por: Wang, Zhuang, et al.
Publicado: (2023)

Molnupiravir for COVID-19
Publicado: (2022)

Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023)

Postvaccine myocarditis and the use of antipyretics: Is there any relation?
por: Fatima, Maurish, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
por: Guermazi, Dorra, et al.
Publicado: (2023)

A surge of pediatric hepatitis: Why SARS-CoV-2 should be considered guilty until proven innocent
por: Nazir, Maheen, et al.
Publicado: (2022)

Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
por: Dufour, Inès, et al.
Publicado: (2023)

Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients
por: Chen, Ping-Jen, et al.
Publicado: (2021)

Development of facial palsy following COVID-19 vaccination: A systematic review
por: Khurshid, Maman, et al.
Publicado: (2022)

Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?
por: Clark, Nicole F., et al.
Publicado: (2022)

Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19
por: Dimosiari, Athina, et al.
Publicado: (2023)

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
por: Liu, Yayun, et al.
Publicado: (2023)

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
por: Kauer, Victoria, et al.
Publicado: (2023)

Singapore’s Dengue Outbreak Amidst the COVID-19 Pandemic: Challenges, Responses, and Lessons
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2023)

Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Tian, Fangyuan, et al.
Publicado: (2023)

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
por: Jayk Bernal, Angélica, et al.
Publicado: (2021)

Efficacy and safety of Paxlovid for COVID-19:a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years
por: Fujita, Kohei, et al.
Publicado: (2023)

Molnupiravir; molecular and functional descriptors of mitochondrial safety
por: Wallace, K.B., et al.
Publicado: (2022)

Successful Hematopoietic Stem Cell Transplantation from a Donor Sibling Infected with SARS-CoV-2 Using Molnupiravir Prophylaxis
por: Mandacı Şanlı, Neslihan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bnedkeviitol4ef2bo5pnmi5s7